from EV Nickel Inc. (isin : DE000A3CMGM5)
EQS-Adhoc: APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
EQS-Ad-hoc: APONTIS PHARMA AG / Key word(s): Personnel
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
10-Jul-2023 / 13:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
Monheim am Rhein, 10 July 2023. The Chief Executive Officer (CEO) of APONTIS PHARMA AG (“APONTIS PHARMA” or “Company“, Ticker APPH / ISIN DE000A3CMGM5), Karlheinz Gast, has informed the Supervisory Board today that he is resigning from his office for personal reasons with immediate effect and that he is leaving the Executive Board.
The Supervisory Board received and accepted Mr. Gast's resignation at its extraordinary meeting today. The service agreement with Mr. Gast will be canceled by mutual agreement.
At the same time, the Supervisory Board appointed Bruno Wohlschlegel as a member of the Executive Board and as CEO for a period of 2 years with an effective date 1 September 2023. Until then, Executive Board member Thomas Milz will manage the Company alone.
APONTIS PHARMA AG
Investor Relations
ir@apontis-pharma.de
T: +49 2173 89 55 4900
F: +49 2173 89 55 1521
Alfred-Nobel-Str. 10
40789 Monheim am Rhein
Germany
apontis-pharma.de
APONTIS PHARMA press contact
CROSS ALLIANCE
Sven Pauly
ir@apontis-pharma.de
T: +49 89 125 09 0330
End of Inside Information
10-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | APONTIS PHARMA AG |
| Alfred-Nobel-Str. 10 | |
| 40789 Monheim | |
| Germany | |
| E-mail: | ir@apontis-pharma.de |
| Internet: | https://apontis-pharma.de/ |
| ISIN: | DE000A3CMGM5 |
| WKN: | A3CMGM |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1676427 |
| End of Announcement | EQS News Service |
1676427 10-Jul-2023 CET/CEST